IBEX LTD (IBEX) Stock Fundamental Analysis

NASDAQ:IBEX • BMG4690M1010

29.98 USD
+0.16 (+0.54%)
At close: Feb 18, 2026
29.98 USD
0 (0%)
After Hours: 2/18/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

IBEX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 87 industry peers in the IT Services industry. IBEX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IBEX is evaluated to be cheap and growing strongly. This does not happen too often! These ratings could make IBEX a good candidate for value and growth and quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • IBEX had positive earnings in the past year.
  • IBEX had a positive operating cash flow in the past year.
  • Each year in the past 5 years IBEX has been profitable.
  • In the past 5 years IBEX always reported a positive cash flow from operatings.
IBEX Yearly Net Income VS EBIT VS OCF VS FCFIBEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

1.2 Ratios

  • IBEX has a Return On Assets of 14.58%. This is amongst the best in the industry. IBEX outperforms 93.10% of its industry peers.
  • With an excellent Return On Equity value of 28.81%, IBEX belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
  • IBEX's Return On Invested Capital of 21.63% is amongst the best of the industry. IBEX outperforms 95.40% of its industry peers.
Industry RankSector Rank
ROA 14.58%
ROE 28.81%
ROIC 21.63%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBEX Yearly ROA, ROE, ROICIBEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • IBEX has a better Profit Margin (7.14%) than 73.56% of its industry peers.
  • In the last couple of years the Profit Margin of IBEX has grown nicely.
  • The Operating Margin of IBEX (9.18%) is better than 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of IBEX has grown nicely.
  • The Gross Margin of IBEX (30.62%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of IBEX has remained more or less at the same level.
Industry RankSector Rank
OM 9.18%
PM (TTM) 7.14%
GM 30.62%
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
IBEX Yearly Profit, Operating, Gross MarginsIBEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBEX is creating value.
  • There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IBEX Yearly Shares OutstandingIBEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
IBEX Yearly Total Debt VS Total AssetsIBEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • IBEX has an Altman-Z score of 4.86. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
  • IBEX has a better Altman-Z score (4.86) than 80.46% of its industry peers.
  • The Debt to FCF ratio of IBEX is 0.05, which is an excellent value as it means it would take IBEX, only 0.05 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of IBEX (0.05) is better than 91.95% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that IBEX is not too dependend on debt financing.
  • The Debt to Equity ratio of IBEX (0.01) is better than 83.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 4.86
ROIC/WACC2.21
WACC9.78%
IBEX Yearly LT Debt VS Equity VS FCFIBEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
  • IBEX has a Current ratio (1.82) which is in line with its industry peers.
  • A Quick Ratio of 1.82 indicates that IBEX should not have too much problems paying its short term obligations.
  • The Quick ratio of IBEX (1.82) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.82
IBEX Yearly Current Assets VS Current LiabilitesIBEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • IBEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.77%, which is quite impressive.
  • IBEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.04% yearly.
  • IBEX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.77%.
  • IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.62% yearly.
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.72% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 9.19% on average over the next years. This is quite good.
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IBEX Yearly Revenue VS EstimatesIBEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
IBEX Yearly EPS VS EstimatesIBEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.66 indicates a reasonable valuation of IBEX.
  • Based on the Price/Earnings ratio, IBEX is valued cheaper than 88.51% of the companies in the same industry.
  • IBEX is valuated cheaply when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 8.28, the valuation of IBEX can be described as very reasonable.
  • 90.80% of the companies in the same industry are more expensive than IBEX, based on the Price/Forward Earnings ratio.
  • IBEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.66
Fwd PE 8.28
IBEX Price Earnings VS Forward Price EarningsIBEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 90.80% of the companies listed in the same industry.
  • IBEX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IBEX is cheaper than 71.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.89
EV/EBITDA 5.4
IBEX Per share dataIBEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • IBEX has a very decent profitability rating, which may justify a higher PE ratio.
  • IBEX's earnings are expected to grow with 13.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)0.21
EPS Next 2Y13.72%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for IBEX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IBEX LTD

NASDAQ:IBEX (2/18/2026, 8:00:01 PM)

After market: 29.98 0 (0%)

29.98

+0.16 (+0.54%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners94.08%
Inst Owner Change-0.03%
Ins Owners2.8%
Ins Owner Change14.36%
Market Cap402.03M
Revenue(TTM)558.27M
Net Income(TTM)41.38M
Analysts45.71
Price Target41.82 (39.49%)
Short Float %0.8%
Short Ratio0.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.95%
Min EPS beat(2)20.05%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)16.83%
Min EPS beat(4)10.89%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)12.58%
EPS beat(12)10
Avg EPS beat(12)14.59%
EPS beat(16)12
Avg EPS beat(16)13.3%
Revenue beat(2)2
Avg Revenue beat(2)5.51%
Min Revenue beat(2)2.5%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.65%
Min Revenue beat(4)2.45%
Max Revenue beat(4)8.52%
Revenue beat(8)5
Avg Revenue beat(8)1.79%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)6.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.48%
EPS NY rev (1m)0%
EPS NY rev (3m)5.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.82%
Valuation
Industry RankSector Rank
PE 8.66
Fwd PE 8.28
P/S 0.69
P/FCF 12.89
P/OCF 7.5
P/B 2.8
P/tB 3.05
EV/EBITDA 5.4
EPS(TTM)3.46
EY11.54%
EPS(NY)3.62
Fwd EY12.08%
FCF(TTM)2.33
FCFY7.76%
OCF(TTM)4
OCFY13.33%
SpS43.23
BVpS10.71
TBVpS9.83
PEG (NY)0.38
PEG (5Y)0.21
Graham Number28.88
Profitability
Industry RankSector Rank
ROA 14.58%
ROE 28.81%
ROCE 26.64%
ROIC 21.63%
ROICexc 24.4%
ROICexgc 26.15%
OM 9.18%
PM (TTM) 7.14%
GM 30.62%
FCFM 5.38%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 129.83%
Cap/Sales 3.86%
Interest Coverage 31.53
Cash Conversion 76.01%
Profit Quality 75.39%
Current Ratio 1.82
Quick Ratio 1.82
Altman-Z 4.86
F-Score8
WACC9.78%
ROIC/WACC2.21
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.48%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year68.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.26%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y19.11%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%

IBEX LTD / IBEX FAQ

Can you provide the ChartMill fundamental rating for IBEX LTD?

ChartMill assigns a fundamental rating of 7 / 10 to IBEX.


What is the valuation status for IBEX stock?

ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.


What is the profitability of IBEX stock?

IBEX LTD (IBEX) has a profitability rating of 7 / 10.


What is the valuation of IBEX LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for IBEX LTD (IBEX) is 8.66 and the Price/Book (PB) ratio is 2.8.


Is the dividend of IBEX LTD sustainable?

The dividend rating of IBEX LTD (IBEX) is 0 / 10 and the dividend payout ratio is 0%.